Australian Construction Stock News

ASX:MIN
ASX:MINMetals and Mining

Is It Too Late To Consider Mineral Resources (ASX:MIN) After 231% One Year Surge?

For investors wondering whether Mineral Resources at A$73.47 is starting to look expensive or if the recent enthusiasm still leaves room for value, this article breaks down what the current price might be implying. The stock has recently posted returns of 5.5% over 7 days, 15.3% over 30 days, 32.5% year to date and 231.1% over the past year, which has put valuation firmly in the spotlight for many investors. Recent news coverage has focused on Mineral Resources in the context of broader...
ASX:AMP
ASX:AMPDiversified Financial

A Look At AMP Limited’s Valuation After The Appointment Of New CFO Jackie Cleary

AMP (ASX:AMP) has drawn fresh attention after appointing Jackie Cleary as Chief Financial Officer, a role that shapes financial policy, reporting, and capital decisions that many investors watch closely. See our latest analysis for AMP. Recent trading reflects a mixed picture, with AMP's share price at A$1.595 and a 30 day share price return of 9.25% and 90 day share price return of 22.69%. The year to date share price return is down 12.84% and the 1 year total shareholder return is...
ASX:MQG
ASX:MQGCapital Markets

Is Macquarie Group (ASX:MQG) Price Reflecting Its Capital Markets Strength Or Too Much Optimism

If you are wondering whether Macquarie Group at around A$238.55 is offering good value or asking too much, the starting point is to get clear on what the current price is really implying. The stock is roughly flat over the past week with a 0.7% decline, while returns of 1.5% over 30 days, 17.1% year to date and 14.9% over 1 year give useful context before looking at any valuation metrics. Recent coverage has focused on Macquarie Group's position in capital markets and its role across asset...
ASX:JHX
ASX:JHXBasic Materials

Is James Hardie (ASX:JHX) Trading Margin for Momentum in Its Latest Growth Guidance?

In May 2026, James Hardie Industries reported fourth-quarter sales of US$1,403.9 million and full-year sales of US$4,835.8 million, alongside lower net income and earnings per share than the prior year. The company also issued guidance calling for first-quarter fiscal 2027 net sales of US$1.32–US$1.35 billion and full-year net sales of US$5.25–US$5.41 billion, giving investors fresh insight into its near-term growth expectations. We’ll now examine how strong top-line growth but weaker...
ASX:S32
ASX:S32Metals and Mining

Are South32’s (ASX:S32) Record Japan Aluminum Premiums Redefining Its Pricing Power Narrative?

Recently, South32 offered Japanese buyers record-high premiums for third-quarter aluminum shipments, reportedly more than US$100 per ton above its prior quarter deals, as supply tightened following conflict-related disruptions in the Middle East. This sharp premium increase at the key Main Japanese Port benchmark underscores how regional supply constraints can rapidly shift pricing power for aluminum producers serving East Asia. We’ll now examine how South32’s record Japan aluminum premiums,...
ASX:NUF
ASX:NUFChemicals

Nufarm (ASX:NUF) Is Up 24.0% After Profit Rose Despite Softer Sales - What's Changed

Nufarm Limited has reported past half-year results to 31 March 2026, with sales of A$1,714.32 million and net income of A$38.2 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. The results highlight that Nufarm generated higher profit and earnings per share despite lower sales, pointing to improved cost control and operating efficiency. Next, we’ll examine how this improvement in earnings despite softer sales might influence...
ASX:GGP
ASX:GGPMetals and Mining

Is Greatland Resources (ASX:GGP) Pricing Reflect Its Recent Share Price Swings And Sector Focus?

Wondering whether Greatland Resources at A$13.65 is offering fair value or a mispriced opportunity? This article breaks down what the current share price might be telling you. The stock is up 4.7% over the past week, while the return over the last 30 days is down 2.4% and the year to date move stands at 29.3%. This may signal shifting views on both growth potential and risk. Recent news coverage around Greatland Resources has focused on its position within the broader materials sector and...
ASX:SIQ
ASX:SIQProfessional Services

A Look At Smartgroup (ASX:SIQ) Valuation After Announcing A A$20 Million Share Buyback

Smartgroup (ASX:SIQ) has outlined a new capital management move, with the board approving a share buyback of up to A$20 million. The buyback will be funded from existing cash reserves and asset sale proceeds. See our latest analysis for Smartgroup. The buyback news comes after a strong run, with the stock posting a 27.4% 1 month share price return and a 65.9% 1 year total shareholder return, while short term moves have eased slightly in recent days. If this kind of capital management story...
ASX:CIA
ASX:CIAMetals and Mining

Champion Iron (ASX:CIA) Margin Improvement To 9.5% Tests Bullish Growth Narrative

Champion Iron (ASX:CIA) has wrapped up FY 2026 with fourth quarter revenue of A$414.5 million and basic EPS of A$0.04, alongside trailing twelve month revenue of A$1.77 billion and EPS of A$0.32 that frame the latest numbers against a fuller year of trading. The company has seen revenue move from A$1.61 billion and EPS of A$0.27 on a trailing basis at the end of FY 2025 to A$1.77 billion and A$0.32 respectively by Q4 2026, while trailing net profit margin sits at 9.5%, presenting this result...
ASX:ARX
ASX:ARXBiotechs

A Look At Aroa Biosurgery’s Valuation After Its Profit Turnaround In Full Year 2026 Results

Why Aroa Biosurgery’s latest earnings matter for ASX:ARX holders Aroa Biosurgery (ASX:ARX) has drawn fresh attention after reporting full year 2026 results, with sales of NZ$103.85 million and a shift from a net loss to a NZ$4.68 million profit. See our latest analysis for Aroa Biosurgery. The latest earnings announcement follows a strong short-term performance, with a 7 day share price return of 13.33% and a 30 day share price return of 21.43%, even though the share price is down 6.85% year...
ASX:SHL
ASX:SHLHealthcare

New CellCarta Companion Diagnostics Partnership Could Be A Game Changer For Sonic Healthcare (ASX:SHL)

Earlier this week, CellCarta announced it had entered a partnership with Sonic Healthcare USA, naming Sonic as the first commercial laboratory partner in its Lab Network to support commercialization of companion diagnostics across oncology, autoimmune disease and other precision medicine areas. This collaboration links CellCarta’s assay development capabilities with Sonic’s broad clinical lab footprint, potentially deepening Sonic’s role in higher-value precision testing and companion...
ASX:EDV
ASX:EDVConsumer Retailing

Endeavour Resets Pinnacle Drinks As Share Price Trails Valuation Estimates

Endeavour Group (ASX:EDV) is restructuring its Pinnacle Drinks business, including a review of its winery footprint and operations. The group plans to sell the Oakridge wine brand and exit or sell other non core winery assets. Winery operations are being consolidated to focus on a tighter set of beverage assets within the Pinnacle portfolio. For investors watching Endeavour Group, this reset follows a period of share price weakness. The stock closed at A$2.86, with the share price down 7.4%...
ASX:FRS
ASX:FRSMetals and Mining

ASX Growth Stocks With Insider Ownership Up To 37%

As Australian shares face a potential retreat, reflecting Wall Street's recent cooling, investors are keenly observing the interplay between local economic indicators and global market trends. In this fluctuating environment, growth companies with substantial insider ownership can be particularly appealing as they often signal confidence from those who know the business best.
ASX:EDU
ASX:EDUConsumer Services

3 Promising ASX Penny Stocks With Market Caps Under A$700M

Australian shares are set for a slight retreat, influenced by market dynamics both locally and internationally, with Wall Street's recent cooling after hitting new highs. In the context of these fluctuating markets, penny stocks—though an older term—remain relevant as they often represent smaller or newer companies with potential for growth at accessible price points. By focusing on those with strong financial health and solid fundamentals, investors can uncover promising opportunities within...
ASX:NUF
ASX:NUFChemicals

Nufarm (ASX:NUF) H1 Profit Of A$28m Tests Long Running Loss Concerns

Nufarm (ASX:NUF) opened H1 2026 with revenue of A$1.7 billion and basic EPS of A$0.07, alongside net income of A$28.0 million. Over the recent half yearly periods, the company has seen revenue move from A$1.8 billion and EPS of A$0.05 in H1 2025 to A$1.6 billion with EPS declining to A$0.54 in H2 2025, before landing at the latest H1 2026 levels. This gives investors a clearer read on how margins are tracking quarter to quarter. Against a backdrop of trailing twelve month losses and analyst...
ASX:SHV
ASX:SHVFood

Select Harvests H1 2026 Margin Slippage Tests Bullish Earnings Narratives

Fresh from its H1 2026 update, Select Harvests (ASX:SHV) is under the spotlight as you weigh recent revenue and EPS trends against the stock’s A$3.90 share price and what they might signal for profitability. The company has seen half year revenue shift from A$226.4 million in H2 2024 to A$293.8 million in H2 2025, while basic EPS over the same periods moved from A$0.03 to A$0.02, setting up a mixed read on earnings momentum. With trailing 12 month net profit margin at 8.4% versus 8.7% in the...